Introduction Of Cervical Cancer Vaccine Delayed

The South Korean authorities have pushed back a decision to include MSD Korea's cervical cancer vaccine, Gardasil, in the national immunisation programme. BMI believes the development is a blow to the manufacturer as it allows GlaxoSmithKline Korea's rival preventative, Cervarix, an opportunity to compete for the lucrative

To read the full article, please take a trial.